Aims & Scope
World Journal of Clinical Cancer Research is a peer-reviewed, open-access clinical oncology journal published by Directive Publications. It disseminates original, internationally relevant scholarship across the spectrum of clinical cancer research, bridging laboratory discovery, diagnosis, treatment, and patient outcomes for a global readership of oncologists, surgeons, radiologists, nuclear-medicine specialists, pathologists, and translational cancer scientists.
The journal welcomes original research, reviews, case reports, and editorials on solid and hematologic malignancies, including hepatocellular carcinoma and locoregional therapies, interventional and nuclear oncology (transarterial radioembolization, Y-90 dosimetry and microspheres), prostate cancer and hormonal therapy, rare and odontogenic tumors, cancer survivorship and quality of life, early detection and screening, and environmental oncology.
We also publish translational and mechanistic studies spanning tumor biology, biomarkers, nanoparticle-based therapeutics, and cancer prevention, alongside clinical-trial reports and methodological work that informs practice and policy.
Every submission undergoes rigorous double-blind peer review. Accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, with authors retaining copyright, and each receives a permanent Crossref DOI. Content is discoverable through OpenAlex and Google Scholar and exposed via an OAI-PMH endpoint, and the journal follows COPE ethical principles to safeguard the integrity of the scholarly record.
Subject Coverage
World Journal of Clinical Cancer Research welcomes original research, reviews, and case reports across the following core areas:
Research Topics
Core subject areas published in World Journal of Clinical Cancer Research — explore related research across our journals.
Articles
The toxicities of laundry products in the home a review and commentary on environmental oncology
Infections caused by Streptococcus bovis were investigated at a monographic oncological centre
Report from a European symposium on how health-care system factors influence referral decisions in patients who may have cancer
Frequently Asked Questions
What topics does the World Journal of Clinical Cancer Research cover?
The journal covers clinical cancer research across solid and hematologic malignancies, including hepatocellular carcinoma and locoregional therapy, interventional and nuclear oncology (transarterial radioembolization and Y-90 dosimetry), prostate cancer and hormonal therapy, rare and odontogenic tumors, cancer survivorship and quality of life, early detection and screening, environmental oncology, and translational tumor biology.
Who should read and publish in the World Journal of Clinical Cancer Research?
It is intended for medical and radiation oncologists, surgical oncologists, interventional radiologists, nuclear-medicine specialists, pathologists, and translational cancer researchers worldwide who study or treat cancer and want their work to reach a broad clinical and scientific audience.
What article types does the World Journal of Clinical Cancer Research accept?
The journal accepts original research articles, narrative and systematic reviews, clinical case reports (such as rare tumor presentations), clinical-trial reports, methodological papers, and editorials addressing the clinical, translational, and preventive dimensions of cancer.
How do I submit a manuscript to the World Journal of Clinical Cancer Research?
Authors submit through the journal's online submission page following the author guidelines for formatting, ethics, and reporting standards. Suitable submissions are screened for scope, then sent for peer review; corresponding authors are notified at each stage of the decision process.
Is the World Journal of Clinical Cancer Research peer-reviewed and open access?
Yes. Every submission undergoes double-blind peer review, and accepted articles are published open access under a Creative Commons Attribution (CC-BY 4.0) licence, so authors retain copyright and readers can freely access, share, and reuse the work with attribution.
Does the journal charge an article-processing fee, and are waivers available?
As an open-access journal, it levies an article-processing charge only on acceptance to cover publishing costs; there are no submission fees. Waivers and discounts are available, particularly for authors from low-resource settings; contact the editorial office for current charges and eligibility.
Will articles receive a DOI and be discoverable in indexes?
Yes. Each accepted article is assigned a permanent Crossref DOI and is discoverable through OpenAlex and Google Scholar, with metadata exposed via an OAI-PMH endpoint for harvesting. The journal also follows COPE ethical principles and is working toward inclusion in additional scholarly indexes.
What makes the World Journal of Clinical Cancer Research distinct in clinical oncology?
The journal emphasizes practice-relevant clinical and interventional oncology, including locoregional and nuclear-medicine therapies and well-documented rare-tumor case reports, while remaining fully open access with global reach, fast and fair double-blind review, and permanent, citable DOIs.